Take a big grain of salt when comparing across trials
A separate product, semaglutide subcutaneous injection (Wegovy), is indicated as an adjunct to lifestyle modifications for weight loss and chronic weight management in obese (BMI 30 kg/m2 or greater) or overweight adults (BMI 27 kg/m2 or greater) with at least 1 weight-related comorbid condition (e.g., hypertension, type 2 diabetes mellitus, or dyslipidemia)
It is rapidly growing and usually asymptomatic, so it is often diagnosed only when the melanomatous lesions are already advanced and there has been metastatic spread to the regional lymph nodes
Nowhere near settled, and absolutely not a reason to swap any part of actual cancer treatment
Baba, Y
High-Purity Research Formulation : Supplied as a lyophilized powder with identity and composition verified through HPLC and mass spectrometry, ensuring consistent laboratory performance and batch-to-batch reliability